Craif Announces Joint Research Results on Early Detection and Prognosis Prediction of Lung Cancer Using Urinary MicroRNA at AACR Annual Meeting 2026
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Craif Inc. announced joint research results at the AACR Annual Meeting 2026 on the early detection and prognosis prediction of lung cancer using urinary microRNA. This research, conducted in collaboration with Tokyo Jikei University School of Medicine and Higashi Osaka Medical Center, demonstrated high-precision diagnosis and recurrence risk prediction through a non-invasive urine test, highlighting the potential for a 'Single-assay concept' in cancer care.